James Hardiman
InvestorGeneral Partner at DCVC (Data Collective) · Board director at Noetik · Board director at Shennon Biotechnologies
San Francisco, California
Writes $5M – $25M checks · typically $15M
About
Has invested at DCVC since 2013, focusing on technologies that characterize, model, or manipulate biological systems, robotics and automation, vertical AI applications, and frontier tech like quantum computing. Previously worked on data-driven sales and marketing strategy for life-science and healthcare companies, with experience in healthcare data analysis, materials R&D, and semiconductor processing.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- j•••@dcvc.comreveal70% confident
Invests in
AI & Machine LearningBiotechQuantum ComputingRobotics
Beyond investing
- Education
- Studied at UC Berkeley (Bachelor's, Engineering Physics) Studied at University of Chicago Booth School of Business (MBA)
From published sources — common ground for a warm intro.
Board director at Noetik
Intro paths
→
In turn, James can intro founders to Noetik's investors below.
Noetik's investors · 9
11.2 CapitalLas Vegas · $500K – $3M checks · since 2023Breakout VenturesSan Francisco · $500K – $6M checksCatalio Capital ManagementNew York · since 2023DCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2022EPIC VENTURESSalt Lake City · since 2023Linearis VenturesQuebec CityNorth South VenturesToronto · since 2023Polaris PartnersBoston · $500K – $5M checks · since 2024Zetta Venture PartnersSan Francisco · $1M – $5M checks · since 2023
Co-founders at Noetik
JR
Jacob RinaldiExecutive Officer, Director, Promoter
RA
Ronald AlfaExecutive Officer, Director, Promoter
RA
Ron Alfa, MD, PhDFounder
Board director at Shennon Biotechnologies
Intro paths
→
In turn, James can intro founders to Shennon Biotechnologies's investors below.
Shennon Biotechnologies's investors · 6
AV8 VenturesPalo Alto · $500K – $10M checks · since 2022DCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2023Foundation CapitalSan Francisco · $250K – $15M checks · since 2022Future VenturesLos Altos · $1M – $10M checks · since 2022NextGen Venture PartnersSan Francisco · $500K – $2M checks · since 2022Samos InvestmentsLondon · since 2022
Co-founders at Shennon Biotechnologies
LS
Li Sun, PhDFounder/CEO
Experience
- Data CollectiveGeneral Partnercurrent2013 — presentSan Francisco Bay Area
- Recursion PharmaceuticalsInvestor and Board Observercurrent2017 — present
- LumafieldInvestor and Board Directorcurrent2020 — present
- Valar LabsInvestor and Board Directorcurrent2023 — present
- NOETIKInvestor and Board Directorcurrent2022 — presentUnited States
- Shennon BiotechnologiesInvestor and Board Directorcurrent2021 — present
- Gradle Inc.Investor and Board Directorcurrent2020 — present
- Stealth Robotics CompanyInvestor and Board Directorcurrent2020 — present
- nTopology inc.Investor and Board Directorcurrent2017 — present
- NiumInvestor and Board Observercurrent2023 — present
- Stealth TechBio CompanyInvestor and Board Observercurrent2022 — presentUnited Kingdom
- AmogyInvestor and Board Observercurrent2021 — present
- Q-CTRLInvestor and Board Observercurrent2018 — present
- Unlearn.AIInvestor and Board Observercurrent2017 — present
- Citrine InformaticsInvestor and Board Observercurrent2016 — present
- Subtle MedicalInvestor and Board Observer2017 — 2024
- Sequence BioInvestor and Board Observer2016 — 2023
- Fortem TechnologiesInvestor and Board Observer2016 — 2022
- The Blackstone GroupSummer Associate2013New York
- ZS AssociatesConsultant2007 — 2012San Mateo, CA
- Lam ResearchR&D2005 — 2007Fremont, California
Skills & more
Strategy7Analysis4Start-upsBig DataValuationEntrepreneurship5FinanceFinancial Modeling5Artificial Intelligence (AI)Machine LearningDue DiligenceMarket Research
+8 more
Business StrategyInvestmentsManagement ConsultingMergers & AcquisitionsStatistical ModelingSegmentationQualitative ResearchVenture CapitalFrom James's professional profile.
Deals · 1
NoetikBoard seat
via DCVC (Data Collective) · filed Sep 2022 · $8M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at DCVC (Data Collective)
Alan Cohen
General Partner at DCVC (Data Collective)
Ali Tamaseb
General Partner at DCVC (Data Collective)
Allyson Kaufman
Investor Relations Partner at DCVC (Data Collective)
Anna Fokina
Investment Director DCVC Bio at DCVC (Data Collective)
Cara Yesko
Associate at DCVC (Data Collective)
Chris Boshuizen
Partner at DCVC (Data Collective)
Christopher Meldrum
Entrepreneur In Residence, DCVC Bio at DCVC Bio
Clay Hutmacher
Operating Partner at DCVC (Data Collective)
Network10
Alan CohenScout
General Partner at DCVC (Data Collective)
Ali TamasebScout
General Partner at DCVC (Data Collective)
Amy SchulmanScout
Managing Partner at Polaris Partners
Anna FokinaScout
Investment Director DCVC Bio at DCVC (Data Collective)
Avidan RossScout
Managing Partner at Root Ventures Manager, Llc
Chris BoshuizenScout
Partner at DCVC (Data Collective)
Chris GibsonScout
Portfolio Director, Private Equity at Bridges Fund Management Ltd.
Dylan ReidScout
Investor at Zetta Venture Partners
Eric Shiozaki, PhDScout
Partner at Revelation Partners
Thiago OlsonScout
Managing Partner at EVE Atlas
Investors connected to James in public investor directories — a warm-intro map.
Frequently asked questions
- Who is James Hardiman?
- Has invested at DCVC since 2013, focusing on technologies that characterize, model, or manipulate biological systems, robotics and automation, vertical AI applications, and frontier tech like quantum computing. Previously worked on data-driven sales and marketing strategy for life-science and healthcare companies, with experience in healthcare data analysis, materials R&D, and semiconductor processing.
- Where does James Hardiman work?
- James Hardiman is General Partner at DCVC (Data Collective) and Board director at Noetik and Board director at Shennon Biotechnologies.
- What does James Hardiman invest in?
- James Hardiman invests in AI & Machine Learning, Biotech, Quantum Computing, Robotics.
- What check size does James Hardiman write?
- James Hardiman typically writes checks of $5M – $25M.
- What boards does James Hardiman sit on?
- James Hardiman holds tracked board seats at Noetik, Shennon Biotechnologies.
- Where did James Hardiman go to school?
- James Hardiman studied at University of California, Berkeley (BS, Engineering Physics); The University of Chicago Booth School of Business (Master of Business Administration (MBA)).
Same school
Also attended University of California, Berkeley1,611
Byron DeeterPartner at Bessemer Venture PartnersSteve WozniakCo-founder of AppleTony XuCo-founder & CEO of DoorDashAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksRyan PetersenFounder & CEO of Flexport
+ 1,605 more
Also attended The University of Chicago Booth School of Business706
Prashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesTinaInvestments & Portfolio Services Team Member at Clear VenturesKatrin GeyskensExecutive Director at Capricorn Venture PartnersBill PescatelloInvestor at LightbankGlebFounder and Managing Partner at iTech Capital
+ 700 more
